Onco360 Announces Hiring Of Kirby Eng, RPh; Will Lead Company’s Clinical Initiatives And Solutions

NEW YORK - June 12, 2014 - PRLog -- Onco360, the largest independent provider of Oncology Pharmacy Services in the U.S., announced today the appointment of Kirby Eng, R.Ph to the position of Executive Director, Clinical Oncology Management Services.   In this role, Mr. Eng will be part of the Onco360 management team and will lead and support teams responsible for helping the organization’s patients and physicians, as well as its hospital, payer, and manufacturer partners navigate the complexities of optimizing Oncology Pharmacy care outcomes.

Known for the depth and breadth of his business and clinical successes throughout his career, Mr. Eng brings to Onco360 over 16 years of Oncology experience and thought leadership, with a strong track record of delivering results.

With complex and rapidly evolving market dynamics in oncology drug therapy, Onco360 is committed to delivering innovative pharmacy care solutions that provide value to patients, physicians, hospitals and health systems, as well as payers and manufacturers.  Burt Zweigenhaft, Vice Chairman of Onco360 said "Kirby Eng is a welcome addition to our team and we look forward to working with him as we expand our national footprint of Oncology Pharmacy and Clinical Support Services."

Mr. Eng’s past experiences include CuraScript, U.S. Oncology, Oncology Therapeutics Network, Sicor Pharmaceuticals and Eli Lilly and Co.  Most recently, Mr. Eng worked for CVS Caremark Specialty where he led and supported oncology drug management initiatives for payer clients.

Mr. Eng is a registered Pharmacist and received his B.S. Pharmacy from the Arnold and Marie Schwartz College of Pharmacy at Long Island University.